Cargando…
Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
Background: Hemolytic uremic syndrome (HUS) is a complex disease with multi-organ involvement. Eculizumab therapy is recommended for treatment of complement mediated hemolytic uremic syndrome (cHUS). However, there are few studies evaluating eculizumab therapy among children with HUS. The primary ob...
Autores principales: | Ranabothu, Saritha, Brown, Clare C., Blaszak, Richard, Millner, Rachel, Moore, Kristen Rice, Prodhan, Parthak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523981/ https://www.ncbi.nlm.nih.gov/pubmed/34676187 http://dx.doi.org/10.3389/fped.2021.733042 |
Ejemplares similares
-
Streptococcus pneumoniae associated hemolytic uremic syndrome in children
por: Young, Heather L., et al.
Publicado: (2023) -
Atypical hemolytic uremic syndrome and eculizumab therapy in children
por: Kim, Seong Heon, et al.
Publicado: (2018) -
Successful Discontinuation of Eculizumab in a Pediatric Patient With Atypical Hemolytic Uremic Syndrome and Underlying Systematic Lupus Erythematosus
por: Alhamoud, Issa, et al.
Publicado: (2022) -
Evaluation of lung ultrasound to detect volume overload in children undergoing dialysis
por: Arthur, Lindsay, et al.
Publicado: (2022) -
Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
por: Palma, Lilian M Pereira, et al.
Publicado: (2016)